<?xml version="1.0" encoding="utf-8"?>
<rss
version="2.0">
<channel xmlns:dc="http://dublincore.org/documents/dcmi-namespace/" xmlns:media="http://search.yahoo.com/mrss/">
<title>Clover Health Investments, Corp.</title>
<link>https://www.globenewswire.com/rssfeed/organization/myjFNpMtjuT-wPiL8DMzXw==</link>
<description>Contains the last 20 releases</description>
<copyright>Copyright 2024, Clover Health Investments, Corp.</copyright>
<managingEditor>newsdesk@globenewswire.com (NewsDesk)</managingEditor>
<lastBuildDate>Wed, 06 Nov 2024 21:05:00 GMT</lastBuildDate>
<webMaster>webmaster@globenewswire.com (Webmaster)</webMaster>
<item>
<guid
isPermaLink="true">https://www.globenewswire.com/news-release/2024/11/06/2976057/0/en/Clover-Health-Reports-Strong-Third-Quarter-2024-Financial-Results-Highlights-Differentiated-Market-Opportunity-to-Grow-Membership.html</guid>
<link>https://www.globenewswire.com/news-release/2024/11/06/2976057/0/en/Clover-Health-Reports-Strong-Third-Quarter-2024-Financial-Results-Highlights-Differentiated-Market-Opportunity-to-Grow-Membership.html</link>
<category
domain="https://www.globenewswire.com/rss/stock">Nasdaq:CLOV</category>
<category
domain="https://www.globenewswire.com/rss/ISIN">US18914F1030</category>
<title>Clover Health Reports Strong Third Quarter 2024 Financial Results; Highlights Differentiated Market Opportunity to Grow Membership</title>
<description><![CDATA[<p align="center"><em>Delivers 9% Total Revenue growth year-to-date compared to prior year period</em></p>]]></description>
<pubDate>Wed, 06 Nov 2024 21:05 GMT</pubDate>
<dc:identifier>2976057</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Wed, 06 Nov 2024 21:05 GMT</dc:modified>
<dc:subject>Earnings Releases and Operating Results</dc:subject>
</item>
<item>
<guid
isPermaLink="true">https://www.globenewswire.com/news-release/2024/10/29/2971221/0/en/Clover-Health-to-Participate-in-Upcoming-Investor-Conferences.html</guid>
<link>https://www.globenewswire.com/news-release/2024/10/29/2971221/0/en/Clover-Health-to-Participate-in-Upcoming-Investor-Conferences.html</link>
<category
domain="https://www.globenewswire.com/rss/stock">Nasdaq:CLOV</category>
<category
domain="https://www.globenewswire.com/rss/ISIN">US18914F1030</category>
<title>Clover Health to Participate in Upcoming Investor Conferences</title>
<description><![CDATA[<p>FRANKLIN, Tenn., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced its participation in the following investor conferences:</p>]]></description>
<pubDate>Tue, 29 Oct 2024 20:05 GMT</pubDate>
<dc:identifier>2971221</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Tue, 29 Oct 2024 20:05 GMT</dc:modified>
<dc:subject>Calendar of Events</dc:subject>
</item>
<item>
<guid
isPermaLink="true">https://www.globenewswire.com/news-release/2024/10/23/2968173/0/en/Clover-Health-to-Report-Third-Quarter-2024-Financial-Results-on-November-6.html</guid>
<link>https://www.globenewswire.com/news-release/2024/10/23/2968173/0/en/Clover-Health-to-Report-Third-Quarter-2024-Financial-Results-on-November-6.html</link>
<category
domain="https://www.globenewswire.com/rss/stock">Nasdaq:CLOV</category>
<category
domain="https://www.globenewswire.com/rss/ISIN">US18914F1030</category>
<title>Clover Health to Report Third Quarter 2024 Financial Results on November 6</title>
<description><![CDATA[<p align="left">FRANKLIN, Tenn., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), today announced that it will report third quarter 2024 financial results after market close on Wednesday, November 6, 2024. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on November 6, 2024, to discuss Clover Health’s third quarter 2024 business and financial results.</p>]]></description>
<pubDate>Wed, 23 Oct 2024 20:05 GMT</pubDate>
<dc:identifier>2968173</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Wed, 23 Oct 2024 20:05 GMT</dc:modified>
<dc:subject>Conference Calls/ Webcasts</dc:subject>
</item>
<item>
<guid
isPermaLink="true">https://www.globenewswire.com/news-release/2024/10/15/2963341/0/en/2025-Clover-Health-Medicare-Advantage-Benefits-Demonstrate-Commitment-to-New-Jersey-Seniors.html</guid>
<link>https://www.globenewswire.com/news-release/2024/10/15/2963341/0/en/2025-Clover-Health-Medicare-Advantage-Benefits-Demonstrate-Commitment-to-New-Jersey-Seniors.html</link>
<category
domain="https://www.globenewswire.com/rss/stock">Nasdaq:CLOV</category>
<category
domain="https://www.globenewswire.com/rss/ISIN">US18914F1030</category>
<title>2025 Clover Health Medicare Advantage Benefits Demonstrate Commitment to New Jersey Seniors</title>
<description><![CDATA[Company’s affordable, benefit-rich flagship PPO plans now have 4 Star rating <pre>Company’s affordable, benefit-rich flagship PPO plans now have 4 Star rating</pre>]]></description>
<pubDate>Tue, 15 Oct 2024 13:15 GMT</pubDate>
<dc:identifier>2963341</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Tue, 15 Oct 2024 13:15 GMT</dc:modified>
<dc:subject>Health</dc:subject>
</item>
<item>
<guid
isPermaLink="true">https://www.globenewswire.com/news-release/2024/10/10/2961727/0/en/Clover-Health-PPO-Medicare-Advantage-Plans-Earn-4-Star-Rating-for-2025.html</guid>
<link>https://www.globenewswire.com/news-release/2024/10/10/2961727/0/en/Clover-Health-PPO-Medicare-Advantage-Plans-Earn-4-Star-Rating-for-2025.html</link>
<category
domain="https://www.globenewswire.com/rss/stock">Nasdaq:CLOV</category>
<category
domain="https://www.globenewswire.com/rss/ISIN">US18914F1030</category>
<title>Clover Health PPO Medicare Advantage Plans Earn 4 Star Rating for 2025</title>
<description><![CDATA[Overall Star rating performance increase was driven by exceptional performance on healthcare quality measures, Medication Adherence and Member Experience <pre>Overall Star rating performance increase was driven by exceptional performance on healthcare quality measures, Medication Adherence and Member Experience</pre>]]></description>
<pubDate>Thu, 10 Oct 2024 21:03 GMT</pubDate>
<dc:identifier>2961727</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Thu, 10 Oct 2024 21:04 GMT</dc:modified>
<dc:subject>Product / Services Announcement</dc:subject>
</item>
<item>
<guid
isPermaLink="true">https://www.globenewswire.com/news-release/2024/10/08/2959513/0/en/Counterpart-Health-Names-David-Tsay-M-D-Ph-D-as-Chief-Medical-Officer.html</guid>
<link>https://www.globenewswire.com/news-release/2024/10/08/2959513/0/en/Counterpart-Health-Names-David-Tsay-M-D-Ph-D-as-Chief-Medical-Officer.html</link>
<category
domain="https://www.globenewswire.com/rss/stock">Nasdaq:CLOV</category>
<category
domain="https://www.globenewswire.com/rss/ISIN">US18914F1030</category>
<title>Counterpart Health Names David Tsay M.D., Ph.D as Chief Medical Officer</title>
<description><![CDATA[Dr. Tsay Brings Unique Expertise in AI, Digital Health, and Clinical Innovation to Counterpart Health <pre>Dr. Tsay Brings Unique Expertise in AI, Digital Health, and Clinical Innovation to Counterpart Health</pre>]]></description>
<pubDate>Tue, 08 Oct 2024 10:15 GMT</pubDate>
<dc:identifier>2959513</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Tue, 08 Oct 2024 10:15 GMT</dc:modified>
<dc:subject>Directors and Officers</dc:subject>
</item>
<item>
<guid
isPermaLink="true">https://www.globenewswire.com/news-release/2024/09/26/2954122/0/en/Clover-Health-Appoints-Seasoned-Healthcare-Executive-as-Chief-Operating-Officer-for-Medicare-Advantage-Operations.html</guid>
<link>https://www.globenewswire.com/news-release/2024/09/26/2954122/0/en/Clover-Health-Appoints-Seasoned-Healthcare-Executive-as-Chief-Operating-Officer-for-Medicare-Advantage-Operations.html</link>
<category
domain="https://www.globenewswire.com/rss/stock">Nasdaq:CLOV</category>
<category
domain="https://www.globenewswire.com/rss/ISIN">US18914F1030</category>
<title>Clover Health Appoints Seasoned Healthcare Executive as Chief Operating Officer for Medicare Advantage Operations</title>
<description><![CDATA[New Jersey Native Joseph Brand to Lead Operational Efficiency and Innovation in MA Operations, Enhancing Care for Physicians and Patients <pre>New Jersey Native Joseph Brand to Lead Operational Efficiency and Innovation in MA Operations, Enhancing Care for Physicians and Patients</pre>]]></description>
<pubDate>Thu, 26 Sep 2024 20:00 GMT</pubDate>
<dc:identifier>2954122</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Thu, 26 Sep 2024 20:00 GMT</dc:modified>
<dc:subject>Directors and Officers</dc:subject>
</item>
<item>
<guid
isPermaLink="true">https://www.globenewswire.com/news-release/2024/09/03/2940072/0/en/The-Iowa-Clinic-Signs-Multi-Year-Agreement-with-Counterpart-Health-to-Deploy-Proven-AI-Technology-to-Hundreds-of-Providers-Across-the-Midwest.html</guid>
<link>https://www.globenewswire.com/news-release/2024/09/03/2940072/0/en/The-Iowa-Clinic-Signs-Multi-Year-Agreement-with-Counterpart-Health-to-Deploy-Proven-AI-Technology-to-Hundreds-of-Providers-Across-the-Midwest.html</link>
<category
domain="https://www.globenewswire.com/rss/stock">Nasdaq:CLOV</category>
<category
domain="https://www.globenewswire.com/rss/ISIN">US18914F1030</category>
<title>The Iowa Clinic Signs Multi-Year Agreement with Counterpart Health to Deploy Proven AI Technology to Hundreds of Providers Across the Midwest</title>
<description><![CDATA[<p align="left">FRANKLIN, Tenn., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Today, <a href="https://www.globenewswire.com/Tracker?data=OW86Z_u1GlHV5j8uUDnJGjTK9q4uucjx9gukhoxsFB-J-pu6NaF9P5ZjtAnav2nyKRJ5ir4lU3OcPm_tp8jpN68ViIFbF48xWOn6Q0cNgZ5P1JWbJYptEEimByNPObqC" rel="nofollow" target="_blank" title=""><u>Counterpart Health, Inc</u></a>. (“Counterpart”), a leading AI-powered physician enablement platform, announced a multi-year agreement with <a href="https://www.globenewswire.com/Tracker?data=sd431ESzER0Wp8Zi4sDLIU9_cUmpBNS8MeiaehYHSXIFLMa6xAOA-GZFEeyr342OHH72jkDdZ93EiSQtDbA0zcJwMwZrAGJdSj4mFpoumGk=" rel="nofollow" target="_blank" title=""><u>The Iowa Clinic, P.C</u></a>., one of the most highly regarded multispecialty healthcare groups in the United States. This deal positions The Iowa Clinic as one of Counterpart's anchor customers in the Midwest, as Counterpart drives a broader strategic expansion across the country. Counterpart is a subsidiary of Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover Health”).<br></p>]]></description>
<pubDate>Tue, 03 Sep 2024 20:05 GMT</pubDate>
<dc:identifier>2940072</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Tue, 03 Sep 2024 20:05 GMT</dc:modified>
<dc:subject>Business Contracts</dc:subject>
<dc:subject>Health</dc:subject>
</item>
<item>
<guid
isPermaLink="true">https://www.globenewswire.com/news-release/2024/08/22/2934249/0/en/Thomas-L-Tran-Former-Chief-Financial-Officer-of-Molina-Healthcare-Joins-Clover-Health-s-Board-of-Directors.html</guid>
<link>https://www.globenewswire.com/news-release/2024/08/22/2934249/0/en/Thomas-L-Tran-Former-Chief-Financial-Officer-of-Molina-Healthcare-Joins-Clover-Health-s-Board-of-Directors.html</link>
<category
domain="https://www.globenewswire.com/rss/stock">Nasdaq:CLOV</category>
<category
domain="https://www.globenewswire.com/rss/ISIN">US18914F1030</category>
<title>Thomas L. Tran, Former Chief Financial Officer of Molina Healthcare, Joins Clover Health’s Board of Directors</title>
<description><![CDATA[<p>FRANKLIN, Tenn., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced it has appointed Thomas L. Tran to the Company’s Board of Directors (the "Board"), and as a member of the Audit Committee.<br></p>]]></description>
<pubDate>Thu, 22 Aug 2024 13:00 GMT</pubDate>
<dc:identifier>2934249</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Thu, 22 Aug 2024 13:00 GMT</dc:modified>
<dc:subject>Directors and Officers</dc:subject>
</item>
<item>
<guid
isPermaLink="true">https://www.globenewswire.com/news-release/2024/08/21/2933837/0/en/Clover-Health-to-Participate-in-Upcoming-2024-Wells-Fargo-Healthcare-Conference.html</guid>
<link>https://www.globenewswire.com/news-release/2024/08/21/2933837/0/en/Clover-Health-to-Participate-in-Upcoming-2024-Wells-Fargo-Healthcare-Conference.html</link>
<category
domain="https://www.globenewswire.com/rss/stock">Nasdaq:CLOV</category>
<category
domain="https://www.globenewswire.com/rss/ISIN">US18914F1030</category>
<title>Clover Health to Participate in Upcoming 2024 Wells Fargo Healthcare Conference</title>
<description><![CDATA[<p>FRANKLIN, Tenn., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced that its Chief Financial Officer, Peter Kuipers, will present at the 2024 Wells Fargo Healthcare Conference on Wednesday, September 4, 2024, at 4:30 p.m. Eastern Time.<br></p>]]></description>
<pubDate>Wed, 21 Aug 2024 20:05 GMT</pubDate>
<dc:identifier>2933837</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Wed, 21 Aug 2024 20:05 GMT</dc:modified>
<dc:subject>Calendar of Events</dc:subject>
<dc:subject>Conference Calls/ Webcasts</dc:subject>
</item>
<item>
<guid
isPermaLink="true">https://www.globenewswire.com/news-release/2024/08/05/2924608/0/en/Clover-Health-Reports-Second-Quarter-2024-Financial-Results-Improves-Full-Year-Guidance-on-Strong-Performance.html</guid>
<link>https://www.globenewswire.com/news-release/2024/08/05/2924608/0/en/Clover-Health-Reports-Second-Quarter-2024-Financial-Results-Improves-Full-Year-Guidance-on-Strong-Performance.html</link>
<category
domain="https://www.globenewswire.com/rss/stock">Nasdaq:CLOV</category>
<category
domain="https://www.globenewswire.com/rss/ISIN">US18914F1030</category>
<title>Clover Health Reports Second Quarter 2024 Financial Results; Improves Full-Year Guidance on Strong Performance</title>
<description><![CDATA[<p align="center"><em>Total Revenue growth for the Second Quarter of 2024 of 11% year-over-year</em><br></p>]]></description>
<pubDate>Mon, 05 Aug 2024 20:05 GMT</pubDate>
<dc:identifier>2924608</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Mon, 05 Aug 2024 20:05 GMT</dc:modified>
<dc:subject>Calendar of Events</dc:subject>
<dc:subject>Earnings Releases and Operating Results</dc:subject>
<dc:subject>Health</dc:subject>
<dc:subject>Conference Calls/ Webcasts</dc:subject>
</item>
<item>
<guid
isPermaLink="true">https://www.globenewswire.com/news-release/2024/07/24/2918355/0/en/Clover-Health-to-Participate-in-Upcoming-2024-KeyBanc-Technology-Leadership-Forum-and-Canaccord-Genuity-44th-Annual-Growth-Conference.html</guid>
<link>https://www.globenewswire.com/news-release/2024/07/24/2918355/0/en/Clover-Health-to-Participate-in-Upcoming-2024-KeyBanc-Technology-Leadership-Forum-and-Canaccord-Genuity-44th-Annual-Growth-Conference.html</link>
<category
domain="https://www.globenewswire.com/rss/stock">Nasdaq:CLOV</category>
<category
domain="https://www.globenewswire.com/rss/ISIN">US18914F1030</category>
<title>Clover Health to Participate in Upcoming 2024 KeyBanc Technology Leadership Forum and Canaccord Genuity 44th Annual Growth Conference</title>
<description><![CDATA[<p>FRANKLIN, Tenn., July 24, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced its participation in the following investor conferences:<br></p>]]></description>
<pubDate>Wed, 24 Jul 2024 20:05 GMT</pubDate>
<dc:identifier>2918355</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Wed, 24 Jul 2024 20:05 GMT</dc:modified>
<dc:subject>Calendar of Events</dc:subject>
</item>
<item>
<guid
isPermaLink="true">https://www.globenewswire.com/news-release/2024/07/22/2916826/0/en/Clover-Health-to-Report-Second-Quarter-2024-Financial-Results-on-August-5.html</guid>
<link>https://www.globenewswire.com/news-release/2024/07/22/2916826/0/en/Clover-Health-to-Report-Second-Quarter-2024-Financial-Results-on-August-5.html</link>
<category
domain="https://www.globenewswire.com/rss/stock">Nasdaq:CLOV</category>
<category
domain="https://www.globenewswire.com/rss/ISIN">US18914F1030</category>
<title>Clover Health to Report Second Quarter 2024 Financial Results on August 5</title>
<description><![CDATA[<p>FRANKLIN, Tenn., July 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced that it will report second quarter 2024 financial results after market close on Monday, August 5, 2024. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on August 5, 2024, to discuss Clover Health’s business and financial results.<br></p>]]></description>
<pubDate>Mon, 22 Jul 2024 20:05 GMT</pubDate>
<dc:identifier>2916826</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Mon, 22 Jul 2024 20:05 GMT</dc:modified>
<dc:subject>Calendar of Events</dc:subject>
<dc:subject>Conference Calls/ Webcasts</dc:subject>
</item>
<item>
<guid
isPermaLink="true">https://www.globenewswire.com/news-release/2024/06/26/2904822/0/en/Clover-Health-Regains-Compliance-with-NASDAQ-Minimum-Bid-Price-Requirement.html</guid>
<link>https://www.globenewswire.com/news-release/2024/06/26/2904822/0/en/Clover-Health-Regains-Compliance-with-NASDAQ-Minimum-Bid-Price-Requirement.html</link>
<category
domain="https://www.globenewswire.com/rss/stock">Nasdaq:CLOV</category>
<category
domain="https://www.globenewswire.com/rss/ISIN">US18914F1030</category>
<title>Clover Health Regains Compliance with NASDAQ Minimum Bid Price Requirement</title>
<description><![CDATA[<p>FRANKLIN, Tenn., June 26, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced that it has received formal notice from The Nasdaq Stock Market, LLC ("Nasdaq") stating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1).</p>]]></description>
<pubDate>Wed, 26 Jun 2024 20:15 GMT</pubDate>
<dc:identifier>2904822</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Wed, 26 Jun 2024 20:15 GMT</dc:modified>
<dc:subject>Health</dc:subject>
<dc:subject>Major shareholder announcements</dc:subject>
</item>
<item>
<guid
isPermaLink="true">https://www.globenewswire.com/news-release/2024/06/14/2898994/0/en/CMS-Improves-Star-Ratings-to-3-5-Stars-for-Clover-Health-PPO-Medicare-Advantage-Plans-for-2025-Payment-Year.html</guid>
<link>https://www.globenewswire.com/news-release/2024/06/14/2898994/0/en/CMS-Improves-Star-Ratings-to-3-5-Stars-for-Clover-Health-PPO-Medicare-Advantage-Plans-for-2025-Payment-Year.html</link>
<category
domain="https://www.globenewswire.com/rss/stock">Nasdaq:CLOV</category>
<category
domain="https://www.globenewswire.com/rss/ISIN">US18914F1030</category>
<title>CMS Improves Star Ratings to 3.5 Stars for Clover Health PPO Medicare Advantage Plans for 2025 Payment Year</title>
<description><![CDATA[The Company previously communicated that CMS had calculated a rating of 3.0 Stars for its PPO plans, impacting payment year 2025. As a result of a recent rating recalculation, CMS has improved that rating to 3.5 Stars for 2025 payment year <pre>The Company previously communicated that CMS had calculated a rating of 3.0 Stars for its PPO plans, impacting payment year 2025. As a result of a recent rating recalculation, CMS has improved that rating to 3.5 Stars for 2025 payment year</pre>]]></description>
<pubDate>Fri, 14 Jun 2024 13:00 GMT</pubDate>
<dc:identifier>2898994</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Fri, 14 Jun 2024 13:00 GMT</dc:modified>
<dc:subject>Major shareholder announcements</dc:subject>
</item>
<item>
<guid
isPermaLink="true">https://www.globenewswire.com/news-release/2024/05/29/2889798/0/en/Clover-Health-Announces-Counterpart-Health-a-New-SaaS-and-Tech-Enabled-Services-Solution-to-Bring-the-Power-of-CA-Technology-to-all-Medicare-Advantage-Payors-and-Providers.html</guid>
<link>https://www.globenewswire.com/news-release/2024/05/29/2889798/0/en/Clover-Health-Announces-Counterpart-Health-a-New-SaaS-and-Tech-Enabled-Services-Solution-to-Bring-the-Power-of-CA-Technology-to-all-Medicare-Advantage-Payors-and-Providers.html</link>
<category
domain="https://www.globenewswire.com/rss/stock">Nasdaq:CLOV</category>
<category
domain="https://www.globenewswire.com/rss/ISIN">US18914F1030</category>
<title>Clover Health Announces Counterpart Health, a New SaaS and Tech Enabled Services Solution to Bring the Power of CA Technology to all Medicare Advantage Payors and Providers</title>
<description><![CDATA[<p>FRANKLIN, Tenn., May 29, 2024 (GLOBE NEWSWIRE) -- <strong>Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”)</strong>, a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, is excited to announce that its flagship clinical decision support tool, Clover Assistant, is now generally available for external payors and providers under the brand name Counterpart Assistant (“CA”). This strategic move with Counterpart Health, a subsidiary of Clover Health, aims to extend the benefits of data-driven proven technology, personalized care to a wider audience, enabling enhanced patient outcomes and reduced healthcare costs across the nation.<br></p>]]></description>
<pubDate>Wed, 29 May 2024 12:00 GMT</pubDate>
<dc:identifier>2889798</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Wed, 29 May 2024 12:01 GMT</dc:modified>
<dc:subject>Health</dc:subject>
<dc:subject>Product / Services Announcement</dc:subject>
</item>
<item>
<guid
isPermaLink="true">https://www.globenewswire.com/news-release/2024/05/07/2877214/0/en/Clover-Health-Reports-Strong-First-Quarter-2024-Financial-Results-Improves-Guidance-to-Target-Full-Year-2024-Adjusted-EBITDA-Profitability.html</guid>
<link>https://www.globenewswire.com/news-release/2024/05/07/2877214/0/en/Clover-Health-Reports-Strong-First-Quarter-2024-Financial-Results-Improves-Guidance-to-Target-Full-Year-2024-Adjusted-EBITDA-Profitability.html</link>
<category
domain="https://www.globenewswire.com/rss/stock">Nasdaq:CLOV</category>
<category
domain="https://www.globenewswire.com/rss/ISIN">US18914F1030</category>
<title>Clover Health Reports Strong First Quarter 2024 Financial Results; Improves Guidance to Target Full-Year 2024 Adjusted EBITDA Profitability</title>
<description><![CDATA[<p align="center"><em>First Quarter 2024 Insurance Revenue growth of 8% year-over-year</em><br></p>]]></description>
<pubDate>Tue, 07 May 2024 20:05 GMT</pubDate>
<dc:identifier>2877214</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Tue, 07 May 2024 20:05 GMT</dc:modified>
<dc:subject>Earnings Releases and Operating Results</dc:subject>
</item>
<item>
<guid
isPermaLink="true">https://www.globenewswire.com/news-release/2024/05/01/2873624/0/en/Clover-Health-to-Participate-at-Bank-of-America-2024-Healthcare-Conference-and-Present-at-2024-Leerink-Partners-Healthcare-Crossroads-Conference.html</guid>
<link>https://www.globenewswire.com/news-release/2024/05/01/2873624/0/en/Clover-Health-to-Participate-at-Bank-of-America-2024-Healthcare-Conference-and-Present-at-2024-Leerink-Partners-Healthcare-Crossroads-Conference.html</link>
<category
domain="https://www.globenewswire.com/rss/stock">Nasdaq:CLOV</category>
<category
domain="https://www.globenewswire.com/rss/ISIN">US18914F1030</category>
<title>Clover Health to Participate at Bank of America 2024 Healthcare Conference and Present at 2024 Leerink Partners Healthcare Crossroads Conference</title>
<description><![CDATA[<p>FRANKLIN, Tenn., May 01, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced its participation in the following investor conferences:<br></p>]]></description>
<pubDate>Wed, 01 May 2024 20:05 GMT</pubDate>
<dc:identifier>2873624</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Wed, 01 May 2024 20:05 GMT</dc:modified>
<dc:subject>Calendar of Events</dc:subject>
<dc:subject>Health</dc:subject>
</item>
<item>
<guid
isPermaLink="true">https://www.globenewswire.com/news-release/2024/04/30/2872800/0/en/Clover-Health-Announces-Inducement-Grant-under-Nasdaq-Listing-Rule-5635-c-4.html</guid>
<link>https://www.globenewswire.com/news-release/2024/04/30/2872800/0/en/Clover-Health-Announces-Inducement-Grant-under-Nasdaq-Listing-Rule-5635-c-4.html</link>
<category
domain="https://www.globenewswire.com/rss/stock">Nasdaq:CLOV</category>
<category
domain="https://www.globenewswire.com/rss/ISIN">US18914F1030</category>
<title>Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)</title>
<description><![CDATA[<p>FRANKLIN, Tenn., April 30, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, announced today that effective April 29, 2024, the Talent and Compensation Committee of the Company’s Board of Directors granted a restricted stock unit award (the “RSUs”) to Peter Kuipers, who will be the Company’s new Chief Financial Officer effective as of the day after filing of our Quarterly Report on Form 10-Q for the quarter-ended March 31, 2024. The RSUs were granted under the Company’s 2022 Inducement Award Plan (the “Inducement Plan”) and will be subject to the terms and conditions of an award agreement and the Inducement Plan.<br></p>]]></description>
<pubDate>Tue, 30 Apr 2024 20:15 GMT</pubDate>
<dc:identifier>2872800</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Tue, 30 Apr 2024 20:15 GMT</dc:modified>
<dc:subject>Major shareholder announcements</dc:subject>
<dc:subject>Exchange announcement</dc:subject>
</item>
<item>
<guid
isPermaLink="true">https://www.globenewswire.com/news-release/2024/04/23/2868114/0/en/Clover-Health-to-Report-First-Quarter-2024-Financial-Results-on-May-7-2024.html</guid>
<link>https://www.globenewswire.com/news-release/2024/04/23/2868114/0/en/Clover-Health-to-Report-First-Quarter-2024-Financial-Results-on-May-7-2024.html</link>
<category
domain="https://www.globenewswire.com/rss/stock">Nasdaq:CLOV</category>
<category
domain="https://www.globenewswire.com/rss/ISIN">US18914F1030</category>
<title>Clover Health to Report First Quarter 2024 Financial Results on May 7, 2024</title>
<description><![CDATA[<p>FRANKLIN, Tenn., April 23, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will report first quarter 2024 financial results after market close on Tuesday, May 7, 2024. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on May 7, 2024, to discuss the Company’s business and financial results.<br></p>]]></description>
<pubDate>Tue, 23 Apr 2024 20:05 GMT</pubDate>
<dc:identifier>2868114</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Tue, 23 Apr 2024 20:05 GMT</dc:modified>
<dc:subject>Calendar of Events</dc:subject>
<dc:subject>Conference Calls/ Webcasts</dc:subject>
</item>
</channel>
</rss>